Literature DB >> 13627740

Clinical evaluation of CB 1348 in malignant lymphoma and related diseases.

L G ISRAELS, D A GALTON, M TILL, E WILTSHAW.   

Abstract

Entities:  

Keywords:  LYMPHOMA/therapy; NITROGEN MUSTARDS/therapeutic use

Mesh：

Substances：

Year:  1958        PMID： 13627740     DOI： 10.1111/j.1749-6632.1958.tb42649.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  3 in total

1.  Chemotherapy in Malignant Disease: The Present Position.

Authors:  A E Buckle
Journal:  Postgrad Med J       Date:  1961-06       Impact factor: 2.401

Review 2.  Antineoplastic and immunosuppressive drugs. I. Biochemical and clinical pharmacological considerations.

Authors:  A H Chalmers; L A Burgoyne; A W Murray
Journal:  Drugs       Date:  1972       Impact factor: 9.546

3.  Fludarabine phosphate for the treatment of low grade lymphoid malignancy.

Authors:  J S Whelan; C L Davis; S Rule; M Ranson; O P Smith; A B Mehta; D Catovsky; A Z Rohatiner; T A Lister
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.